IL17A and breast cancer: “MAPK signaling pathway”, “Colorectal cancer”, “IL-17 signaling pathway”, “Human T-cell leukemia virus 1 infection”, “Parathyroid hormone synthesis, secretion and action”, “TNF signaling pathway”, “Osteoclast differentiation”, “Prion diseases”, “Thyroid cancer”, “Breast cancer”, “Cellular senescence”, “JAK-STAT signaling pathway”, “Hepatitis B”, “PI3K-Akt signaling pathway”, “Endometrial cancer”, “Kaposi sarcoma-associated herpesvirus infection”, “Transcriptional misregulation in cancer” were significantly enriched KEGG pathways.